Transcription Factor Oct1 Is a Somatic and Cancer Stem Cell Determinant

English version České info

Defining master transcription factors governing somatic and cancer stem cell identity is an important goal. Here we show that the Oct4 paralog Oct1, a transcription factor implicated in stress responses, metabolic control, and poised transcription states, regulates normal and pathologic stem cell function. Oct1^HI cells in the colon and small intestine co-express known stem cell markers. In primary malignant tissue, high Oct1 protein but not mRNA levels strongly correlate with the frequency of CD24^LOCD44^HI cancer-initiating cells. Reducing Oct1 expression via RNAi reduces the proportion of ALDH^HI and dye efflux^HI cells, and increasing Oct1 increases the proportion of ALDH^HI cells. Normal ALDH^HI cells harbor elevated Oct1 protein but not mRNA levels. Functionally, we show that Oct1 promotes tumor engraftment frequency and promotes hematopoietic stem cell engraftment potential in competitive and serial transplants. In addition to previously described Oct1 transcriptional targets, we identify four Oct1 targets associated with the stem cell phenotype. Cumulatively, the data indicate that Oct1 regulates normal and cancer stem cell function.

Vyšlo v časopise: Transcription Factor Oct1 Is a Somatic and Cancer Stem Cell Determinant. PLoS Genet 8(11): e32767. doi:10.1371/journal.pgen.1003048
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pgen.1003048

Souhrn

Zdroje

1. KimCF, JacksonEL, WoolfendenAE, LawrenceS, BabarI, et al. (2005) Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell 121: 823–835.

2. EmaH, TakanoH, SudoK, NakauchiH (2000) In vitro self-renewal division of hematopoietic stem cells. J Exp Med 192: 1281–1288.

3. ClaytonE, DoupeDP, KleinAM, WintonDJ, SimonsBD, et al. (2007) A single type of progenitor cell maintains normal epidermis. Nature 446: 185–189.

4. HeXC, YinT, GrindleyJC, TianQ, SatoT, et al. (2007) PTEN-deficient intestinal stem cells initiate intestinal polyposis. Nat Genet 39: 189–198.

5. PottenCS, BoothC, TudorGL, BoothD, BradyG, et al. (2003) Identification of a putative intestinal stem cell and early lineage marker; musashi-1. Differentiation 71: 28–41.

6. Al-HajjM, WichaMS, Benito-HernandezA, MorrisonSJ, ClarkeMF (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 100: 3983–3988.

7. BonnetD, DickJE (1997) Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 3: 730–737.

8. YilmazOH, ValdezR, TheisenBK, GuoW, FergusonDO, et al. (2006) Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells. Nature 441: 475–482.

9. GinestierC, HurMH, Charafe-JauffretE, MonvilleF, DutcherJ, et al. (2007) ALDH1 Is a Marker of Normal and Malignant Human Mammary Stem Cells and a Predictor of Poor Clinical Outcome. Cell Stem Cell 1: 555–567.

10. LiuS, GinestierC, Charafe-JauffretE, FocoH, KleerCG, et al. (2008) BRCA1 regulates human mammary stem/progenitor cell fate. Proc Natl Acad Sci U S A 105: 1680–1685.

11. BoikoAD, RazorenovaOV, van de RijnM, SwetterSM, JohnsonDL, et al. (2010) Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271. Nature 466: 133–137.

12. ReyaT, MorrisonSJ, ClarkeMF, WeissmanIL (2001) Stem cells, cancer, and cancer stem cells. Nature 414: 105–111.

13. DiehnM, ChoRW, LoboNA, KaliskyT, DorieMJ, et al. (2009) Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature 458: 780–783.

14. PhillipsTM, McBrideWH, PajonkF (2006) The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation. J Natl Cancer Inst 98: 1777–1785.

15. BaoS, WuQ, McLendonRE, HaoY, ShiQ, et al. (2006) Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444: 756–760.

16. DierksC, BeigiR, GuoGR, ZirlikK, StegertMR, et al. (2008) Expansion of Bcr-Abl-positive leukemic stem cells is dependent on Hedgehog pathway activation. Cancer Cell 14: 238–249.

17. FarnieG, ClarkeRB (2007) Mammary stem cells and breast cancer-role of notch signalling. Stem Cell Rev 3: 169–175.

18. SanchoE, BatlleE, CleversH (2004) Signaling pathways in intestinal development and cancer. Annu Rev Cell Dev Biol 20: 695–723.

19. KangJ, ShakyaA, TantinD (2009) Stem cells, stress, metabolism and cancer: a drama in two Octs. Trends Biochem Sci 34: 491–499.

20. ShakyaA, KangJ, ChumleyJ, WilliamsMA, TantinD (2011) Oct1 is a switchable, bipotential stabilizer of repressed and inducible transcriptional states. J Biol Chem 286: 450–459.

21. ShakyaA, CookseyR, CoxJE, WangV, McClainDA, et al. (2009) Oct1 loss of function induces a coordinate metabolic shift that opposes tumorigenicity. Nat Cell Biol 11: 320–327.

22. TsatmaliM, WalcottEC, CrossinKL (2005) Newborn neurons acquire high levels of reactive oxygen species and increased mitochondrial proteins upon differentiation from progenitors. Brain Res 1040: 137–150.

23. SmithJ, LadiE, Mayer-ProschelM, NobleM (2000) Redox state is a central modulator of the balance between self-renewal and differentiation in a dividing glial precursor cell. Proc Natl Acad Sci U S A 97: 10032–10037.

24. LiuJ, CaoL, ChenJ, SongS, LeeIH, et al. (2009) Bmi1 regulates mitochondrial function and the DNA damage response pathway. Nature 459: 387–392.

25. MohyeldinA, Garzon-MuvdiT, Quinones-HinojosaA (2010) Oxygen in Stem Cell Biology: A Critical Component of the Stem Cell Niche. Cell Stem Cell 7: 150–161.

26. TantinD, Schild-PoulterC, WangV, HacheRJ, SharpPA (2005) The octamer binding transcription factor Oct-1 is a stress sensor. Cancer Res 65: 10750–10758.

27. AlmeidaR, AlmeidaJ, ShoshkesM, MendesN, MesquitaP, et al. (2005) OCT-1 is over-expressed in intestinal metaplasia and intestinal gastric carcinomas and binds to, but does not transactivate, CDX2 in gastric cells. J Pathol 207: 396–401.

28. HuangEH, HynesMJ, ZhangT, GinestierC, DontuG, et al. (2009) Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis. Cancer Res 69: 3382–3389.

29. HessDA, WirthlinL, CraftTP, HerrbrichPE, HohmSA, et al. (2006) Selection based on CD133 and high aldehyde dehydrogenase activity isolates long-term reconstituting human hematopoietic stem cells. Blood 107: 2162–2169.

30. WongVW, StangeDE, PageME, BuczackiS, WabikA, et al. (2012) Lrig1 controls intestinal stem-cell homeostasis by negative regulation of ErbB signalling. Nat Cell Biol 14: 401–408.

31. PowellAE, WangY, LiY, PoulinEJ, MeansAL, et al. (2012) The pan-ErbB negative regulator Lrig1 is an intestinal stem cell marker that functions as a tumor suppressor. Cell 149: 146–158.

32. BarkerN, van EsJH, KuipersJ, KujalaP, van den BornM, et al. (2007) Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 449: 1003–1007.

33. de LauW, BarkerN, LowTY, KooBK, LiVS, et al. (2011) Lgr5 homologues associate with Wnt receptors and mediate R-spondin signalling. Nature 476: 293–297.

34. CarmonKS, GongX, LinQ, ThomasA, LiuQ (2011) R-spondins function as ligands of the orphan receptors LGR4 and LGR5 to regulate Wnt/beta-catenin signaling. Proc Natl Acad Sci U S A 108: 11452–11457.

35. SangiorgiE, CapecchiMR (2008) Bmi1 is expressed in vivo in intestinal stem cells. Nat Genet 40: 915–920.

36. Charafe-JauffretE, GinestierC, IovinoF, WicinskiJ, CerveraN, et al. (2009) Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature. Cancer Res 69: 1302–1313.

37. DeRoseYS, WangG, LinYC, BernardPS, BuysSS, et al. (2011) Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes. Nat Med 17: 1514–1520.

38. YanagawaY, ChenJC, HsuLC, YoshidaA (1995) The transcriptional regulation of human aldehyde dehydrogenase I gene. The structural and functional analysis of the promoter. J Biol Chem 270: 17521–17527.

39. WuC, AlmanBA (2008) Side population cells in human cancers. Cancer Lett 268: 1–9.

40. SummerR, KottonDN, SunX, MaB, FitzsimmonsK, et al. (2003) Side population cells and Bcrp1 expression in lung. Am J Physiol Lung Cell Mol Physiol 285: L97–104.

41. GoodellMA, BroseK, ParadisG, ConnerAS, MulliganRC (1996) Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J Exp Med 183: 1797–1806.

42. ZhouS, SchuetzJD, BuntingKD, ColapietroAM, SampathJ, et al. (2001) The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat Med 7: 1028–1034.

43. ScharenbergCW, HarkeyMA, Torok-StorbB (2002) The ABCG2 transporter is an efficient Hoechst 33342 efflux pump and is preferentially expressed by immature human hematopoietic progenitors. Blood 99: 507–512.

44. BirneyE, StamatoyannopoulosJA, DuttaA, GuigoR, GingerasTR, et al. (2007) Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature 447: 799–816.

45. SebastianoV, DalvaiM, GentileL, SchubartK, SutterJ, et al. (2010) Oct1 regulates trophoblast development during early mouse embryogenesis. Development 137: 3551–3560.

46. WangVEH, SchmidtT, ChenJ, SharpPA, TantinD (2004) Embryonic Lethality, Decreased Erythopoiesis, and Defective Octamer-Dependent Promoter Activation in Oct-1-Deficient Mice. Mol Cell Biol 24: 1022–1032.

47. WangVE, TantinD, ChenJ, SharpPA (2004) B cell development and immunoglobulin transcription in Oct-1-deficient mice. Proc Natl Acad Sci U S A 101: 2005–2010.

48. ItoK, HiraoA, AraiF, MatsuokaS, TakuboK, et al. (2004) Regulation of oxidative stress by ATM is required for self-renewal of haematopoietic stem cells. Nature 431: 997–1002.

49. DonnerAL, EpiskopouV, MaasRL (2007) Sox2 and Pou2f1 interact to control lens and olfactory placode development. Dev Biol 303: 784–799.

50. MunozJ, StangeDE, SchepersAG, van de WeteringM, KooBK, et al. (2012) The Lgr5 intestinal stem cell signature: robust expression of proposed quiescent ‘+4’ cell markers. Embo J 31: 3079–3091.

51. BroadleyKW, HunnMK, FarrandKJ, PriceKM, GrassoC, et al. (2011) Side population is not necessary or sufficient for a cancer stem cell phenotype in glioblastoma multiforme. Stem Cells 29: 452–461.

52. QuintanaE, ShackletonM, SabelMS, FullenDR, JohnsonTM, et al. (2008) Efficient tumour formation by single human melanoma cells. Nature 456: 593–598.

53. LiL, LiM, SunC, FranciscoL, ChakrabortyS, et al. (2011) Altered hematopoietic cell gene expression precedes development of therapy-related myelodysplasia/acute myeloid leukemia and identifies patients at risk. Cancer Cell 20: 591–605.

54. ReymannS, BorlakJ (2008) Transcription profiling of lung adenocarcinomas of c-myc-transgenic mice: identification of the c-myc regulatory gene network. BMC Syst Biol 2: 46.

55. Ben-PorathI, ThomsonMW, CareyVJ, GeR, BellGW, et al. (2008) An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet 40: 499–507.

56. SomervailleTC, MathenyCJ, SpencerGJ, IwasakiM, RinnJL, et al. (2009) Hierarchical maintenance of MLL myeloid leukemia stem cells employs a transcriptional program shared with embryonic rather than adult stem cells. Cell Stem Cell 4: 129–140.

57. MattisonJ, KoolJ, UrenAG, de RidderJ, WesselsL, et al. (2010) Novel Candidate Cancer Genes Identified by a Large-Scale Cross-Species Comparative Oncogenomics Approach. Cancer Res 70: 883–895.

58. KangJ, GoodmanB, ZhengY, TantinD (2011) Dynamic Regulation of Oct1 during Mitosis by Phosphorylation and Ubiquitination. PLoS ONE 6: e23872 doi:10.1371/journal.pone.0023872

59. WangP, JinT (2010) Hydrogen peroxide stimulates nuclear import of the POU homeodomain protein Oct-1 and its repressive effect on the expression of Cdx-2. BMC Cell Biol 11: 56.

60. WangP, WangQ, SunJ, WuJ, LiH, et al. (2009) POU homeodomain protein Oct-1 functions as a sensor for cyclic AMP. J Biol Chem 284: 26456–26465.

61. KangJ, GemberlingM, NakamuraM, WhitbyFG, HandaH, et al. (2009) A general mechanism for transcription regulation by Oct1 and Oct4 in response to genotoxic and oxidative stress. Genes Dev 23: 208–222.

62. ItoK, HiraoA, AraiF, TakuboK, MatsuokaS, et al. (2006) Reactive oxygen species act through p38 MAPK to limit the lifespan of hematopoietic stem cells. Nat Med 12: 446–451.

63. NemethMJ, KirbyMR, BodineDM (2006) Hmgb3 regulates the balance between hematopoietic stem cell self-renewal and differentiation. Proc Natl Acad Sci U S A 103: 13783–13788.

64. ParkIK, QianD, KielM, BeckerMW, PihaljaM, et al. (2003) Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature 423: 302–305.

65. TothovaZ, KolliparaR, HuntlyBJ, LeeBH, CastrillonDH, et al. (2007) FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress. Cell 128: 325–339.

66. TrowbridgeJJ, SnowJW, KimJ, OrkinSH (2009) DNA methyltransferase 1 is essential for and uniquely regulates hematopoietic stem and progenitor cells. Cell Stem Cell 5: 442–449.

67. PhelpsRA, ChidesterS, DehghanizadehS, PhelpsJ, SandovalIT, et al. (2009) A two-step model for colon adenoma initiation and progression caused by APC loss. Cell 137: 623–634.

68. PatrawalaL, CalhounT, Schneider-BroussardR, ZhouJ, ClaypoolK, et al. (2005) Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2− cancer cells are similarly tumorigenic. Cancer Res 65: 6207–6219.

69. ChoS, SpangrudeGS (2011) Enrichment of Functionally Distinct Mouse Hematopoietic Progenitor Cell Populations using CD62L. J Immunol 187: 5203–5210.

70. ShackletonM, VaillantF, SimpsonKJ, StinglJ, SmythGK, et al. (2006) Generation of a functional mammary gland from a single stem cell. Nature 439: 84–88.